Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications

Cholangiocarcinoma — novel biological insights and therapeutic strategies

(2023) Sumera I. Ilyas et al.   Nature Reviews Clinical Oncology

FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement

(2022) Timil H. Patel et al.   CLINICAL CANCER RESEARCH

Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center

(2022) Camilla Nero et al.   Journal of Personalized Medicine

Futibatinib: First Approval

(2022) Yahiya Y. Syed   DRUGS

Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?

(2022) Gael S. Roth et al.   EUROPEAN JOURNAL OF CANCER

A Computational Framework for Comprehensive Genomic Profiling in Solid Cancers: The Analytical Performance of a High-Throughput Assay for Small and Copy Number Variants

(2022) Luciano Giacò et al.   Cancers

Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of Infigratinib

(2021) James Yu et al.   OncoTargets and Therapy

BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic

(2020) Angelo Minucci et al.   MOLECULAR BIOLOGY REPORTS

Molecular profile of BRCA-mutated biliary tract cancers

(2020) Gilbert Spizzo et al.   ESMO Open

Validation of the Oncomine™ focus panel for next-generation sequencing of clinical tumour samples

(2018) Hannah L. Williams et al.   VIRCHOWS ARCHIV

Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report

(2018) Yuan Cheng et al.   OncoTargets and Therapy

Overall Survival and Clinical Characteristics of BRCA‐Associated Cholangiocarcinoma: A Multicenter Retrospective Study

(2017) Talia Golan et al.   ONCOLOGIST

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

(2017) Apinya Jusakul et al.   Cancer Discovery

Clinical impact on ovarian cancer patients of massive parallel sequencing forBRCAmutation detection: the experience at Gemelli hospital and a literature review

(2015) Angelo Minucci et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility

(2015) Mark E. Robson et al.   JOURNAL OF CLINICAL ONCOLOGY

Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation

(2015) Bella Kaufman et al.   JOURNAL OF CLINICAL ONCOLOGY

Genomic spectra of biliary tract cancer

(2015) Hiromi Nakamura et al.   NATURE GENETICS

Mutation Profiling in Cholangiocarcinoma: Prognostic and Therapeutic Implications

(2014) Chaitanya R. Churi et al.   PLoS One

Comparative In Vitro and In Silico Analyses of Variants in Splicing Regions of BRCA1 and BRCA2 Genes and Characterization of Novel Pathogenic Mutations

(2013) Mara Colombo et al.   PLoS One